Clinical Trial Update: Prevention of Osteoporosis in Men With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial on preventing osteoporosis in men with prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Osteoporosis
• Prostate Cancer

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Prostate Cancer, Osteoporosis | Phase 3 | Status: COMPLETED